BioSpace News Archive

A new Government scheme announced today selects the UroLift® System as one of seven innovations across all specialisms that are the most transformative for NHS patients

Brinavess® (vernakalant hydrochloride) is for the rapid conversion of recent onset atrial fibrillation

ForaCare, Inc. and PointClickCare are announcing an integration of FORA medical devices and the PointClickCare platform.

Newest foundry catalyzes synthetic biology for pharmaceutical applications, empowering accessible and scalable R&D for therapeutics

Medline Discovery Hub invites clinicians attending ANCC National Magnet Conference to evaluate intuitively designed solutions before they hit market

BioLab Sciences, an innovator in regenerative medicine technologies, today announced its exclusively licensed technology for MyOwn SkinT

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced the publication of a study in the peer-reviewed journal, Nature Gene Therapy

EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, announced today that two abstracts on the use of neflamapimod as a treatment for Early Alzheimer’s disease will be presented at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) conference

Bausch + Lomb, a global eye health company and a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE:/TSX:BHC), and IBM (NYSE: IBM) today announced the new eyeTELLIGENCE™ applications which will run on the IBM Cloud to help eye surgeons and surgical facilities work more efficiently

Stem cell discoverer Prof. James Till, Professor Emeritus, University of Toronto, Canada who was awarded the Edogawa Niche Prize 2018 (www.edogawanicheprize.org), jointly by Nichi-In Centre for Regenerative Medicine (NCRM) and Jinsei-sha-Edogawa Hospital, Tokyo, Japan, has donated his prize money of One million Japanese Yen to establish a travel grant that will be named as “Joyce and James Till Travel Grant”.